| First Author | Hatini PG | Year | 2019 |
| Journal | Brain Res | Volume | 1724 |
| Pages | 146399 | PubMed ID | 31445030 |
| Mgi Jnum | J:282158 | Mgi Id | MGI:6380317 |
| Doi | 10.1016/j.brainres.2019.146399 | Citation | Hatini PG, et al. (2019) Serotonin abnormalities in Dravet syndrome mice before and after the age of seizure onset. Brain Res 1724:146399 |
| abstractText | Dravet syndrome (DS) is a genetic form of severe epilepsy often associated with mutation of the SCN1A gene encoding the voltage gated sodium channel Nav1.1. Typically refractive to conventional therapy, serotonin neurotransmission may be an innovative target for treatment. To further understand the role of serotonin in this disorder, in this study we examined the state of the endogenous serotonin system in an Scn1a(+/-) mouse model of DS. Examined at an age before seizures appear, we found the hypothermic effect of 5-HT1A receptor agonist administration was attenuated. HPLC analysis of brain monoamine content revealed modestly reduced serotonin levels in tissue samples of the midbrain that included the dorsal raphe nucleus but no changes elsewhere in the brain. The reduced sensitivity to 5-HT1A agonist administration seen at young ages reversed after the age of seizure development when mice showed an exaggerated hypothermic response. Likewise, adult DS mice showed a pronounced hypersensitivity to a 5-HT2A/2C agonist. As adults however monoamine levels were not detectably altered. Thus there are alterations in the endogenous serotonin system that both precede and follow the appearance of seizure in DS mice, most strikingly in the response to agonist administration. |
